Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last kr143.20 SEK
Change Today -2.20 / -1.51%
Volume 726.2K
MEDAA On Other Exchanges
As of 11:30 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

meda ab-a shs (MEDAA) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/13/15 - kr152.00
52 Week Low
10/16/14 - kr85.61
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDA AB-A SHS (MEDAA)

Related News

No related news articles were found.

meda ab-a shs (MEDAA) Related Businessweek News

No Related Businessweek News Found

meda ab-a shs (MEDAA) Details

Meda AB operates as a specialty pharmaceutical company worldwide. It manufactures and sells specialty pharmaceutical products, branded generics, over-the-counter drugs, and other products in various therapy areas, such as respiratory, dermatology, gastroenterology, cardiology, pain and inflammation, and CNS, as well as metabolism/vitamins. The company markets and sells its products through distributors in approximately 150 countries. Meda AB is headquartered in Solna, Sweden.

4,516 Employees
Last Reported Date: 04/8/15

meda ab-a shs (MEDAA) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: kr17.0M
Compensation as of Fiscal Year 2014.

meda ab-a shs (MEDAA) Key Developments

Meda AB Recommends Amendment to Articles of Association

Meda AB recommended amendment of articles of association to the approval at its upcoming annual general meeting going to be held on May 6, 2015.

Meda AB Proposes Dividend, Payable on May 13, 2015

The board of Meda AB proposed an unchanged dividend of SEK 2.50, and that the record date for the dividend shall be May 8, 2015. If AGM participants approve this proposal, the dividend is expected to be distributed under the direction of Euroclear Sweden AB on May 13, 2015, and the last day for trading Meda shares that include dividend rights will be May 6, 2015.

Meda AB Proposes Election of Kimberly Lein-Mathisen and Lillie Li Valeur as New Board Members

Meda AB announced that the nomination committee proposed the election of Kimberly Lein-Mathisen and Lillie Li Valeur as new board members. Kimberly has been CEO of Lilleborg within the Orkla Group for two years and she has 12 years of experience in senior international positions at Eli Lilly, among others as General Manager of the company's second large subsidiary, which is located in Germany. Kimberly is an external Board member of NHST Media Group. Lillie Li Valeur has been working for 13 years at Arla, and is now Vice President for South East Asia. She has previous experience in the pharmaceutical and OTC business from Novartis and Lundbeck. Lillie is an external Board member of AarhusKarlshamn AB. The appointments will be consider at the AGM to be held on May 6, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MEDAA:SS kr143.20 SEK -2.20

MEDAA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actelion Ltd SFr.126.90 CHF +2.90
Astellas Pharma Inc ¥1,948 JPY -27.50
H Lundbeck A/S kr132.10 DKK +2.00
Moberg Pharma AB kr48.00 SEK -0.20
Shire PLC 5,615 GBp -20.00
View Industry Companies

Industry Analysis


Industry Average

Valuation MEDAA Industry Range
Price/Earnings 100.0x
Price/Sales 3.0x
Price/Book 2.3x
Price/Cash Flow 118.4x
TEV/Sales 1.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDA AB-A SHS, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at